FDA 483 - Effingham Equity - June 06, 2023

Effingham Equity, a medicated feed manufacturer in Effingham, IL, was cited for two significant issues during an FDA inspection. The firm failed to implement adequate preventive controls for aflatoxins in corn, specifically regarding sampling and analysis procedures. Additionally, the company did not perform required periodic assays for medicated feeds manufactured in 2022.